Association of opioid use with response to immune checkpoint inhibitors.

被引：0
作者：
Weinfeld, Michael
Wang, Heidy
Liu, Li C.
Pasquinelli, Mary
Huber, Michael
Feldman, Lawrence Eric
Weinberg, Frank
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[3] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
[4] Jesse Brown VA Med Ctr, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14595
引用
收藏
页数：1
相关论文
共 50 条
[41]   Genetic determinants of adverse events in cancer patients receiving immune checkpoint inhibitors. [J].
Abdel-Wahab, Noha ;
Yu, Robert K. ;
Diab, Adi ;
Dadu, Ramona ;
Shannon, Vickie ;
Futreal, Andrew ;
Criswell, Lindsey A. ;
Shete, Sanjay ;
Suarez-Almazor, Maria E. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[42]   Diabetes and Immune Checkpoint Inhibitors-Response [J].
Cortellini, Alessio ;
D'Alessio, Antonio ;
Pinato, David J. .
CLINICAL CANCER RESEARCH, 2023, 29 (19) :4017-4018
[43]   Predictive biomarkers of response to immune checkpoint inhibitors [J].
Sacramento Diaz-Carrasco, Maria ;
Gonzalez-Haba, Eva ;
Ines Garcia-Soler, Juana ;
Espuny-Miro, Alberto .
FARMACIA HOSPITALARIA, 2020, 44 (04) :141-148
[44]   Immune-related adverse events after ≥12 months of starting immune checkpoint inhibitors. [J].
Jovaisaite, Agne ;
Serrano, Marina ;
Jackson-Spence, Francesca ;
Young, Matthew ;
Toms, Charlotte ;
Wang, Yishen ;
Nally, Elizabeth ;
Szabados, Bernadett ;
Powles, Thomas .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[45]   Predictive biomarkers of response to immune checkpoint inhibitors [J].
Frelau, Alexandra ;
Pracht, Marc ;
Le Sourd, Samuel ;
Lespagnol, Alexandra ;
Corre, Romain ;
Menard, Cedric ;
Tarte, Karin ;
Mosser, Jean ;
Edeline, Julien .
BULLETIN DU CANCER, 2018, 105 :S80-S91
[46]   Understanding Suboptimal Response to Immune Checkpoint Inhibitors [J].
Zhu, Mojun ;
Zhang, Henan ;
Pedersen, Katrina S. ;
Foster, Nathan R. ;
Jaszewski, Brandy L. ;
Liu, Xin ;
Hirdler, Jacob B. ;
An, Zesheng ;
Bekaii-Saab, Tanios S. ;
Halfdanarson, Thorvardur R. ;
Boland, Patrick M. ;
Yan, Yiyi ;
Hubbard, Joleen H. ;
Ma, Wen Wee ;
Yoon, Harry H. ;
Revzin, Alexander ;
Fernandez-Zapico, Martin E. ;
Overman, Michael J. ;
McWilliams, Robert R. ;
Dong, Haidong .
ADVANCED BIOLOGY, 2023, 7 (04)
[47]   Sarcoid-Like Reaction in Patients Undergoing Treatment with Immune Checkpoint Inhibitors. [J].
Dostzada, Khaled ;
Reed, Marc ;
Eichhorn, Joshua .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[48]   Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature [J].
Guerra, Nestor Lopez ;
Matas-Garcia, Ana ;
Serra-Garcia, Laura ;
Morgado-Carrasco, Daniel ;
Padrosa, Joan ;
Aldecoa, Iban ;
Duque, Yaiza ;
Casal-Dominguez, Maria ;
Munoz-Braceras, Sandra ;
Aranega, Raquel ;
Moreno-Lozano, Pedro ;
Canto-Santos, Judith ;
Garrabou, Gloria ;
Ruiz-Ortiz, Estibaliz ;
Trallero-Araguas, Ernesto ;
Selva-O'Callaghan, Albert ;
Grau, Josep M. ;
Puig, Susana ;
Torres-Ruiz, Jiram ;
Mammen, Andrew L. ;
Fernandez, Iago Pinal ;
Milisenda, Jose C. .
AUTOIMMUNITY REVIEWS, 2023, 22 (08)
[49]   Physician awareness of immune-related adverse events from checkpoint inhibitors. [J].
Khalid, Ahmed Bilal ;
Jalal, Shadia Ibrahim ;
Drum, Greg Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[50]   Incidence and economic burden of infections in cancer patients receiving immune checkpoint inhibitors. [J].
Nalluru, Swarna Sri ;
Piranavan, Paramarajan ;
Narimiti, Anvesh ;
Shah, Shanil ;
Siddiqui, Ahmad Daniyal ;
Abraham, George .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345